US Stock MarketDetailed Quotes
MRSN Mersana Therapeutics
- 2.575
- -0.055-2.09%
Trading Nov 14 13:21 ET
318.10MMarket Cap-4291P/E (TTM)
2.786High2.535Low328.86KVolume2.780Open2.630Pre Close867.96KTurnover0.45%Turnover RatioLossP/E (Static)123.53MShares6.28052wk High321.88P/B187.86MFloat Cap1.22052wk Low--Dividend TTM72.96MShs Float29.090Historical High--Div YieldTTM9.54%Amplitude0.801Historical Low2.639Avg Price1Lot Size
About Mersana Therapeutics Company
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.
Company Profile
SymbolMRSN
Company NameMersana Therapeutics
Listing DateJun 28, 2017
Issue Price15.00
Founded2001
CEODr. Martin H. Huber, M.D.
MarketNASDAQ
Employees123
Fiscal Year Ends12-31
Address840 Memorial Drive
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-498-0020
Websitehttp://www.mersana.com
Company Executives
- Name
- Position
- Salary
- Dr. Martin H. Huber, M.D.
- Director, President and Chief Executive Officer
- 2.60M
- Mohan Bala
- Senior Vice President and Chief Development Officer
- 1.58M
- Alejandra Carvajal
- Senior Vice President and Chief Legal Officer
- 1.61M
- Brian DeSchuytner
- Senior Vice President, Chief Operating Officer and Chief Financial Officer
- 1.74M
- Dr. Tushar Misra, PhD
- Senior Vice President and Chief Manufacturing Officer
- --
- Dr. Timothy B. Lowinger, PhD
- Senior Vice President, Chief Science and Technology Officer
- 1.69M
- Ashish Mandelia
- Vice President, Controller and Principal Accounting Officer
- --
- David M. Mott
- Chairman of the Board
- 329.93K
- Anna Protopapas
- Director
- 4.45M
- Lawrence M. Alleva
- Independent Director
- 308.93K
- Dr. Willard H. Dere, M.D.
- Independent Director
- 305.43K
- Allene M. Diaz
- Independent Director
- 294.93K
- Dr. Kristen M. Hege, M.D.
- Independent Director
- 293.43K
- Dr. Andrew A. F. Hack, M.D.,PhD
- Independent Director
- 297.43K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
